KORRO BIO INC (KRRO) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:KRRO • US5009461089

12.26 USD
-0.44 (-3.46%)
At close: Feb 4, 2026
12.32 USD
+0.06 (+0.49%)
After Hours: 2/4/2026, 8:00:03 PM
Fundamental Rating

3

Overall KRRO gets a fundamental rating of 3 out of 10. We evaluated KRRO against 524 industry peers in the Biotechnology industry. KRRO has a great financial health rating, but its profitability evaluates not so good. KRRO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • KRRO had negative earnings in the past year.
  • KRRO had a negative operating cash flow in the past year.
  • In the past 5 years KRRO always reported negative net income.
  • KRRO had a negative operating cash flow in each of the past 5 years.
KRRO Yearly Net Income VS EBIT VS OCF VS FCFKRRO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M -80M

1.2 Ratios

  • KRRO has a Return On Assets (-54.73%) which is comparable to the rest of the industry.
  • KRRO's Return On Equity of -89.28% is in line compared to the rest of the industry. KRRO outperforms 49.24% of its industry peers.
Industry RankSector Rank
ROA -54.73%
ROE -89.28%
ROIC N/A
ROA(3y)-50.75%
ROA(5y)-35.9%
ROE(3y)-63.13%
ROE(5y)-44.24%
ROIC(3y)N/A
ROIC(5y)N/A
KRRO Yearly ROA, ROE, ROICKRRO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

  • KRRO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KRRO Yearly Profit, Operating, Gross MarginsKRRO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

More info and screens

7

2. Health

2.1 Basic Checks

  • KRRO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, KRRO has more shares outstanding
  • Compared to 5 years ago, KRRO has less shares outstanding
  • There is no outstanding debt for KRRO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
KRRO Yearly Shares OutstandingKRRO Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
KRRO Yearly Total Debt VS Total AssetsKRRO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • Based on the Altman-Z score of -3.01, we must say that KRRO is in the distress zone and has some risk of bankruptcy.
  • KRRO has a Altman-Z score (-3.01) which is in line with its industry peers.
  • KRRO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -3.01
ROIC/WACCN/A
WACC8.92%
KRRO Yearly LT Debt VS Equity VS FCFKRRO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 6.71 indicates that KRRO has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 6.71, KRRO is in the better half of the industry, outperforming 68.51% of the companies in the same industry.
  • A Quick Ratio of 6.71 indicates that KRRO has no problem at all paying its short term obligations.
  • KRRO has a Quick ratio of 6.71. This is in the better half of the industry: KRRO outperforms 68.70% of its industry peers.
Industry RankSector Rank
Current Ratio 6.71
Quick Ratio 6.71
KRRO Yearly Current Assets VS Current LiabilitesKRRO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

1

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 71.29% over the past year.
  • KRRO shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -39.89% yearly.
EPS 1Y (TTM)71.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.04%
Revenue 1Y (TTM)N/A
Revenue growth 3Y-45.55%
Revenue growth 5Y-39.89%
Sales Q2Q%N/A

3.2 Future

  • KRRO is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.16% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y2.29%
EPS Next 2Y8.05%
EPS Next 3Y3.56%
EPS Next 5Y1.16%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KRRO Yearly Revenue VS EstimatesKRRO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M
KRRO Yearly EPS VS EstimatesKRRO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 -20 -40 -60 -80 -100

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for KRRO. In the last year negative earnings were reported.
  • Also next year KRRO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KRRO Price Earnings VS Forward Price EarningsKRRO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KRRO Per share dataKRRO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.05%
EPS Next 3Y3.56%

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for KRRO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

KORRO BIO INC

NASDAQ:KRRO (2/4/2026, 8:00:03 PM)

After market: 12.32 +0.06 (+0.49%)

12.26

-0.44 (-3.46%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-12
Earnings (Next)03-16
Inst Owners103.86%
Inst Owner Change-0.33%
Ins Owners1.54%
Ins Owner Change7.36%
Market Cap115.49M
Revenue(TTM)7.37M
Net Income(TTM)-88.42M
Analysts71.25
Price Target45.9 (274.39%)
Short Float %12.39%
Short Ratio3.27
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)11.34%
Min EPS beat(2)-4.75%
Max EPS beat(2)27.43%
EPS beat(4)3
Avg EPS beat(4)9.89%
Min EPS beat(4)-4.75%
Max EPS beat(4)27.43%
EPS beat(8)6
Avg EPS beat(8)-113.02%
EPS beat(12)9
Avg EPS beat(12)-73.09%
EPS beat(16)11
Avg EPS beat(16)-85.18%
Revenue beat(2)2
Avg Revenue beat(2)133.12%
Min Revenue beat(2)84.81%
Max Revenue beat(2)181.42%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-52.06%
EPS NQ rev (1m)4.45%
EPS NQ rev (3m)19.82%
EPS NY rev (1m)2.69%
EPS NY rev (3m)11.33%
Revenue NQ rev (1m)-14.22%
Revenue NQ rev (3m)28.63%
Revenue NY rev (1m)0.27%
Revenue NY rev (3m)13.18%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 15.67
P/FCF N/A
P/OCF N/A
P/B 1.17
P/tB 1.17
EV/EBITDA N/A
EPS(TTM)-9.41
EYN/A
EPS(NY)-7.82
Fwd EYN/A
FCF(TTM)-7.46
FCFYN/A
OCF(TTM)-7.26
OCFYN/A
SpS0.78
BVpS10.51
TBVpS10.51
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -54.73%
ROE -89.28%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-50.75%
ROA(5y)-35.9%
ROE(3y)-63.13%
ROE(5y)-44.24%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 38.62%
Cap/Sales 25.59%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.71
Quick Ratio 6.71
Altman-Z -3.01
F-Score4
WACC8.92%
ROIC/WACCN/A
Cap/Depr(3y)307.52%
Cap/Depr(5y)347.56%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)71.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.04%
EPS Next Y2.29%
EPS Next 2Y8.05%
EPS Next 3Y3.56%
EPS Next 5Y1.16%
Revenue 1Y (TTM)N/A
Revenue growth 3Y-45.55%
Revenue growth 5Y-39.89%
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y12.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-63.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-59.04%
OCF growth 3YN/A
OCF growth 5YN/A

KORRO BIO INC / KRRO FAQ

Can you provide the ChartMill fundamental rating for KORRO BIO INC?

ChartMill assigns a fundamental rating of 3 / 10 to KRRO.


Can you provide the valuation status for KORRO BIO INC?

ChartMill assigns a valuation rating of 0 / 10 to KORRO BIO INC (KRRO). This can be considered as Overvalued.


Can you provide the profitability details for KORRO BIO INC?

KORRO BIO INC (KRRO) has a profitability rating of 1 / 10.